Zoetis

Open: 198.0 Close: 195.92 Change: -2.08

The top 7 things about Zoetis found by an AI.

The game is changing. There is a new strategy to evaluate Zoetis fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Zoetis are: Zoetis, share, sell, price, company, recently, report, and the …

Concept Map

Semantic Network

Stock Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. Zoetes offers products primarily across species, including livestock, such as cattle, swine, poultry, fish,.

Today's Summary

Zoetis Inc.s (NYse:zts) share price could signal some risk. The company recently reported that it has 3.34 million shares sold short.

Today's News

Zoetis stock has received a consensus rating of buy. The 21 analysts offering price forecasts for the company have a median target of 217.43, with a high estimate of 260.00 and a low estimate of 180.00. The high in the last 52 weeks was 201.91, according to the current price, which is 97.72% away from the low. Zoetis Inc.s (NYse:zts) share price could signal some risk. Zoetis price-to-earnings ratio of 39.5x might make it look like a strong sell compared to the market in the U.S. Territory Business Manager (Business Development - Other) in US KS Remote at Zoetis. We are seeking a highly capable individual for Territory Business. Manager (business development - other) in us. Zoetis Inc. is trading ex-dividend on January 18th, 2024 with 0.432 USD Dividend Per Share December 8th - $Zoetis(ZOetisUS)$ is trading. The company recently reported that it has 3.34 million shares sold short, which is 0.73%. Jefferies analyst Glen Santangelo assumes Zoetis (NYSE: ZTS ) with a Buy rating and announces Price Target of $230. Zoetis has declared a dividend of $0.432 per share for the first quarter of 2024, an increase of 15% from the quarterly dividend. Zoetiss (NYSE:ZTS) short percent of float has risen 10.61% since its last report. The company recently reported that it has 3.34 million shares sold short. Zoetis has outperformed the market over the past 5 years by 3.99% on an annualized basis producing an average annual return of 15.54%. The company recently reported that it has 3.34 million shares sold short, which is 0.73% of all regular shares. Zoetis has an average price target of $218.88. Eight analysts have rated the stock with a buy rating, based on data from MarketBeat. CEO Kristin C. Takeda recently sold shares worth $500K. Zoetis vs. merck: With return forecast of 13%, zoetis is a better bet. Zoeti shares sold by foundations investment advisors llc - defense world. (NYse:zts) shares sold.

Stock Profile

"Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey."

Keywords

How much time have you spent trying to decide whether investing in Zoetis? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Zoetis are: Zoetis, share, sell, price, company, recently, report, and the most common words in the summary are: zoetis, stock, best, market, pet, price, news, . One of the sentences in the summary was: Zoetis Inc.s (NYse:zts) share price could signal some risk. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #zoetis #stock #best #market #pet #price #news.